Shares of Ocular Therapeutix (OCUL) have gained 4% over the past four weeks to close the last trading session at $11.48, but there could still be a solid upside left in the stock if short-term price targets of Wall Street analysts are any indication. Going by the price targets, the mean estimate of$21 indicates a potential upside of 82.9%.The mean estimate comprises 12 short-term price targets with a standard deviation of $4.92. While the lowest estimate of$14.00 indicates a 22% increase from the current ...